As competition in the pharmaceutical industry continues to increase, quality assurance (QA) management will need to reevaluate the role of their organizations within the corporation. QA units must downplay the traditional “policeman” role and assume a more constructive role. The key to this new role is confirming that data bases meet corporate and regulatory standards and evaluating the sense/nonsense of regulatory submissions for management.
